The most common medications dispensed to lactating persons: An electronic health record‐based approach

Using a novel, electronic health record (EHR)‐based approach, to estimate the prevalence of prescription medication use at 2, 4, and 6 months postpartum among lactating individuals.

[1]  M. Loane,et al.  Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert , 2022, International Breastfeeding Journal.

[2]  V. Foulon,et al.  Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries , 2022, International journal of environmental research and public health.

[3]  C. Good,et al.  Twelve month oral contraceptive pill prescriptions: Role of policy mandates on utilization , 2021, Exploratory research in clinical and social pharmacy.

[4]  S. Caritis,et al.  Obstetrical, fetal, and lactation pharmacology-a crisis that can no longer be ignored. , 2021, American journal of obstetrics and gynecology.

[5]  K. Vesco,et al.  Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination , 2021, Therapeutic advances in drug safety.

[6]  P. Anderson.  Antidepressants and Breastfeeding. , 2020, Breastfeeding Medicine.

[7]  C. Spong,et al.  Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule , 2020, JAMA network open.

[8]  C. F. Gravenkemper.  Dicloxacillin , 2020, Reactions weekly.

[9]  T. Cheng.  Levothyroxine. , 2020, Journal of the American Medical Association (JAMA).

[10]  Fluoxetine , 2019, Reactions Weekly.

[11]  D. Tucker,et al.  Antidepressant prescriptions, discontinuation, depression and perinatal outcomes, including breastfeeding: A population cohort analysis , 2019, PloS one.

[12]  H. Ritchie,et al.  Calls to a Major Teratogen Information Service Regarding Exposures During Breastfeeding. , 2019, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[13]  Cathi B. Propper,et al.  The Mood, Mother, and Infant Study: Associations Between Maternal Mood in Pregnancy and Breastfeeding Outcome. , 2019, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[14]  K. Rothman,et al.  Identification and validation of uterine perforation, intrauterine device expulsion, and breastfeeding in four health care systems with electronic health records , 2019, Clinical epidemiology.

[15]  A. Xiang,et al.  Breastfeeding Persistence at 6 Months: Trends and Disparities from 2008 to 2015 , 2019, The Journal of pediatrics.

[16]  C. Spong,et al.  "Is It Safe?" - The Many Unanswered Questions about Medications and Breast-Feeding. , 2019, New England Journal of Medicine.

[17]  Stuart J. Watson,et al.  Breastfeeding, Antidepressants, and Depression in the Mercy Pregnancy and Emotional Well-Being Study , 2019, Journal of human lactation : official journal of International Lactation Consultant Association.

[18]  M. van Weissenbruch,et al.  Medication Use During Pregnancy and Lactation in a Dutch Population , 2018, Journal of human lactation : official journal of International Lactation Consultant Association.

[19]  S. Ferguson,et al.  Why does the need for medication become a barrier to breastfeeding? A narrative review. , 2017, Women and birth : journal of the Australian College of Midwives.

[20]  J. Morrison,et al.  Antidepressant Use in Late Gestation and Breastfeeding Rates at Discharge from Hospital , 2017, Journal of human lactation : official journal of International Lactation Consultant Association.

[21]  C. Chambers,et al.  Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary , 2017, Clinical pharmacology and therapeutics.

[22]  R. Gagnayre,et al.  Knowledge, Representations, Attitudes, and Behaviors of Women Faced With Taking Medications While Breastfeeding , 2017, Journal of human lactation : official journal of International Lactation Consultant Association.

[23]  S. Kochhar.  UK medical eligibility criteria for contraceptive use , 2016 .

[24]  K. Curtis,et al.  U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[25]  Catherine M Sherwin,et al.  Calls to a teratogen information service regarding potential exposures in pregnancy and breastfeeding , 2016, BMC Pharmacology and Toxicology.

[26]  K. Ryan,et al.  Postpartum women’s use of medicines and breastfeeding practices: a systematic review , 2015, International Breastfeeding Journal.

[27]  Sonia Hernández-Díaz,et al.  The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program , 2015, Obstetrics and gynecology.

[28]  Cynthia J. Vaughn.  Drugs and Lactation Database: LactMed , 2012 .

[29]  Sarah J. Beaton,et al.  Medication Exposure in Pregnancy Risk Evaluation Program , 2012, Maternal and Child Health Journal.

[30]  C. Chambers,et al.  Breastfeeding among Women Exposed to Antidepressants during Pregnancy , 2012, Journal of human lactation : official journal of International Lactation Consultant Association.

[31]  R. Negro,et al.  2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.

[32]  J. Trussell.  Medical eligibility criteria for contraceptive use , 2011 .

[33]  Sonia Hernández-Díaz,et al.  Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. , 2011, American journal of obstetrics and gynecology.

[34]  B. Hanusa,et al.  Are maternal depression or symptom severity associated with breastfeeding intention or outcomes? , 2010, The Journal of clinical psychiatry.

[35]  D. Kennedy,et al.  MotherSafe: Review of three years of counselling by an Australian teratology Information Service , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[36]  Richard Platt,et al.  Use of prescription medications with a potential for fetal harm among pregnant women , 2006, Pharmacoepidemiology and drug safety.

[37]  J. Guillebaud,et al.  Medical eligibility criteria for contraceptive use , 2018, Advanced Health Assessment of Women.

[38]  D. Alexander,et al.  The National Institute of Child Health and Human Development , 1965, Nature.

[39]  Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule. , 2014, Federal register.

[40]  A. P. Kiriushchenkov.  [Lactational mastitis]. , 1979, Fel'dsher i akusherka.